Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug could reduce IV dependence for short bowel patients

NCT ID NCT04775706

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times

Summary

This study tests an experimental drug called HM15912 (sonefpeglutide) in 18 adults with short bowel syndrome who need IV nutrition. The goal is to see if the drug is safe and can help the intestines absorb more nutrients, potentially reducing the need for IV support. Participants receive either the drug or a placebo injection, and researchers monitor side effects and bowel function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asklepios Klinik St. Georg

    RECRUITING

    Hamburg, Free and Hanseatic City of Hamburg, 20099, Germany

  • Brigham & Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • Central Middlesex Hospital

    RECRUITING

    London, NW10 7NS, United Kingdom

  • Centre Hospitalier Universitaire de Bordeaux

    RECRUITING

    Bordeaux, 33000, France

  • Centre Hospitalier Universitaire de Nice

    RECRUITING

    Nice, 06300, France

  • Hopital Beaujon

    RECRUITING

    Clichy, Clichy, 92110, France

  • Les Hospices Civils de Lyon

    RECRUITING

    Lyon, 69002, France

  • Rigshospitalet Department of Digestive Diseases, Transplantation and General Surgery Section for Intestinal Failure

    RECRUITING

    Copenhagen, 2100, Denmark

  • Salford Royal Hospital

    RECRUITING

    Salford, Greater Manchester, M6 8HD, United Kingdom

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • The Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • UZ Leuven

    RECRUITING

    Leuven, Vlaams Brabant, 3000, Belgium

  • Universitätsklinikum Tübingen

    RECRUITING

    Tübingen, Tübingen, 72076, Germany

  • Wojewodzki Specjalistyczny Szpital im. Mikołaja Pirogowa w Łodzi

    RECRUITING

    Lodz, Łódź Voivodeship, 90-531, Poland

Conditions

Explore the condition pages connected to this study.